Exact Sciences and Genomic Health in $2.8bn merger

31-07-2019

Rory O'Neill

Exact Sciences and Genomic Health in $2.8bn merger

Exact Sciences will acquire Genomic Health in a merger deal worth $2.8 billion.


Exact Sciences, Genomic Health, merger, acquisition, Cologuard, Oncotype DX, diagnostics, cancer

LSIPR